Cite
Bramante CT, Ingraham NE, Murray TA, et al. Metformin and risk of mortality in patients hospitalised with COVID-19: a retrospective cohort analysis. Lancet Healthy Longev. 2020;2(1):e34-e41doi: 10.1016/S2666-7568(20)30033-7.
Bramante, C. T., Ingraham, N. E., Murray, T. A., Marmor, S., Hovertsen, S., Gronski, J., McNeil, C., Feng, R., Guzman, G., Abdelwahab, N., King, S., Tamariz, L., Meehan, T., Pendleton, K. M., Benson, B., Vojta, D., & Tignanelli, C. J. (2021). Metformin and risk of mortality in patients hospitalised with COVID-19: a retrospective cohort analysis. The Lancet. Healthy longevity, 2(1), e34-e41. https://doi.org/10.1016/S2666-7568(20)30033-7
Bramante, Carolyn T, et al. "Metformin and risk of mortality in patients hospitalised with COVID-19: a retrospective cohort analysis." The Lancet. Healthy longevity vol. 2,1 (2021): e34-e41. doi: https://doi.org/10.1016/S2666-7568(20)30033-7
Bramante CT, Ingraham NE, Murray TA, Marmor S, Hovertsen S, Gronski J, McNeil C, Feng R, Guzman G, Abdelwahab N, King S, Tamariz L, Meehan T, Pendleton KM, Benson B, Vojta D, Tignanelli CJ. Metformin and risk of mortality in patients hospitalised with COVID-19: a retrospective cohort analysis. Lancet Healthy Longev. 2021 Jan;2(1):e34-e41. doi: 10.1016/S2666-7568(20)30033-7. Epub 2020 Dec 03. PMID: 33521772; PMCID: PMC7832552.
Copy
Download .nbib